Agilent’s Postnatal Assay Gets European IVDR Class C Certification
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read MorePosted by Andy Lundin | Apr 15, 2024 | Womens Health |
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read MorePosted by Andy Lundin | Apr 12, 2024 | Company News, Molecular Diagnostics |
The facility has been designed to manufacture the company’s Co-Dx Pro instrument and test cups for the new platform.
Read MorePosted by Chris Wolski | Apr 9, 2024 | Molecular Diagnostic Analyzers |
There is a potential to use T-cell diagnostics to diagnose underlying post-viral syndromes by measuring the bodies adaptive immune resistance.
Read MorePosted by Andy Lundin | Apr 8, 2024 | Diagnostic Technologies |
The new diagnostic tool combines optofluidics and nanopore technology to create a lab-on-a-chip diagnostic system.
Read MorePosted by Andy Lundin | Apr 2, 2024 | Covid 19 |
The COVID test is cleared for those aged 14 or older when self-testing, and those aged two and older when administered by an adult.
Read More